B Phillips, K Nylander, J Harnaha, J Machen, … - Diabetes, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Microspheres carrying antisense oligonucleotides
to CD40, CD80, and CD86 were delivered into NOD mice. Glycemia was monitored to
determine disease prevention and reversal. In recipients that remained ... Cited by 9 - Related articles - All 11 versions
D Elias, A Avron, M Tamir, I Raz - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2006 - interscience.wiley.com Abstract: DiaPep277 is an immunomodulatory peptide that arrests β cell
destruction in mouse models of type 1 diabetes mellitus (T1DM). This article
extends an original pilot observation to two studies of 61 patients (age > ... Cited by 4 - Related articles - BL Direct - All 4 versions
M Yoshida, JE Babensee - Journal of Biomaterials Science, Polymer Edition, 2006 - ingentaconnect.com Abstract—The ability of immature dendritic cells (iDCs) derived from human
peripheral blood mononuclear cells to phagocytose poly(lactic-co-glycolic acid)
(PLGA) microparticles (MPs) as compared to polystyrene MPs and the ... Cited by 12 - Related articles - BL Direct - All 5 versions
AH Enk - Ernst Schering Research Foundation workshop, 2006 - ncbi.nlm.nih.gov Regulatory T cells (Treg) in broader terms consist of different subsets of T
cells that are characterized by their ability to suppress proliferation of
conventional effector T cells by various means. To date, three main groups ... Cited by 8 - Related articles
M Nouri-Shirazi, AW Thomson - Expert Opin. Biol. Ther., 2006 - informahealthcare.com Dendritic cells (DCs) play a crucial role during the initiation of immune
responses against non-self antigens. Following organ transplantation, activated
donor- and recipient-derived DCs participate actively in graft rejection by ... Cited by 17 - Related articles - BL Direct - All 5 versions
C Ionescu-Tîrgoviºte - Acta Endocrinologica (Buc), 2009 - 82.76.72.38 Abstract Based on epidemiological, clinic, biochemical and hormonal data (both
personal and international), our personal view is that natural history of
autoimmune type 1 diabetes could include the following stages: 1) The ... Related articles - View as HTML - All 2 versions
AP Acharya, MJ Clare-Salzler, BG … - Biomaterials, 2009 - Elsevier Immunogenomic a combined with advances in adjuvant immunology are guiding
progress toward rational design of vaccines. Furthermore, drug delivery
platforms (eg, synthetic particles) are demonstrating promise for ... Related articles - All 2 versions
B Phillips, N Giannoukakis, M Trucco - Expert Review of Clinical Immunology, 2009 - ingentaconnect.com Dendritic cell (DC) immunotherapy is a clinical reality. Despite two decades of
considerable data demonstrating the feasibility of using DCs to prolong
transplant allograft survival and to prevent autoimmunity, only now are ... Related articles - All 3 versions
